Siemens Aktiengesellschaft (SMAWF)
NEUTRALファンダメンタル
62
株価
$334.00
時価総額
$249.04B
パート1 · 企業の価値
概要
Siemens sells the automation equipment, software and electrical infrastructure that factories, buildings and rail systems run on, plus it majority-owns Siemens Healthineers, a separately listed medical-imaging and diagnostics company. Its factory-automation and infrastructure businesses sell to industrial and construction customers worldwide; its rail unit builds trains and signaling systems for transit operators. The common thread across the divisions is selling equipment and software that customers depend on for years, not months.
収益の仕組み
Revenue comes mostly from selling hardware and software for factory automation, building systems and rail equipment, often bundled with long-term service and maintenance contracts that generate recurring income after the initial sale. Siemens Healthineers, consolidated into group results even though it trades as its own stock, adds revenue from selling and servicing imaging machines and diagnostic equipment to hospitals, a business with its own multi-year sales and service cycle.
セグメント別売上高
Majority-owned, separately listed medical technology business selling imaging and diagnostic equipment to hospitals; Siemens' largest segment.
Electrical products, building automation and grid technology sold to construction and utility customers.
Factory automation hardware and industrial software used to design and run manufacturing plants; the segment that declined in fiscal 2025.
Trains, rail infrastructure and signaling systems sold to public transit operators and railways.
競争優位性(moat)
スイッチングコスト · 狭いOnce a factory or hospital is built around Siemens automation systems, imaging equipment or signaling technology, replacing it means retraining staff and requalifying processes, which discourages switching for years. The advantage is narrow rather than wide because each division faces capable global rivals — Schneider Electric and Rockwell in automation, GE Healthcare and Philips in imaging, Alstom in rail — that win contracts on price and features.
需要を左右する要因
景気循環型Industrial automation spending tracks factory investment cycles, which slow when manufacturers cut capital budgets in a downturn, and rail and infrastructure orders depend on large, lumpy public and private capital projects. Healthineers is the exception: hospital spending on imaging and diagnostics is comparatively steady, which softens the swings from the more industrial divisions.
強気材料
Buyers point to steady growth at Smart Infrastructure and Mobility, resilient demand for Healthineers' hospital equipment, and long-lived customer relationships across the automation business as reasons the group can keep compounding revenue even as one division has a soft year.
弱気材料
Sellers worry that Digital Industries' decline signals weaker manufacturing capital spending that could spread to other divisions in a broader downturn, and that running four largely unrelated global businesses, one of them a separately listed subsidiary, makes the group harder to value and manage than a set of focused competitors.
Written by the editors, published on 2026年8月18日
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
貸借対照表と流動性
売上高
$81.12B
直近12か月(2026/6/30まで)
純利益
$7.95B
直近12か月(2026/6/30まで)
フリーキャッシュフロー
$6.50B
自己資本合計
$72.70B
負債合計
$49.92B
流動比率
1.44
利払い倍率
-
負債/EBITDA
3.99
一株当たり利益(EPS)
売上高と純利益
フリーキャッシュフロー
収益内訳
財務推移表
利益率の推移
負債の推移
負債の重さ
成長率グリッド
成長率 — 売上高
適正価値の推定
適正価値
$257.48
現在株価
$334.00
安全マージン
-29.7%
適正価値レンジ
$167.36 - $347.59
推定方法
バリュエーション指標
P/E レシオ
27.93
ROE
12.5%
P/B レシオ
3.43
P/FCF
38.29
粗利益率
39.4%
ROIC
7.8%
収益性レーダー
Value Creation (Economic Moat)
ROIC
7.8%
WACC
9.7%
ROIC − WACC
-1.9 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
ファンダメンタル分析基準
合格(13)
- Price CAGR 10.34%
- ROIC 7.8%
- Gross Margin 39.4%
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- ROE 12.2%
- Revenue Growth 5Y 7.4%
- Analyst Consensus 74% Buy
- PEG Ratio 1.37
- Earnings Quality (OCF/NI) 1.49
- Net Margin Trend 12.2% vs 10.9%
不合格(6)
- P/FCF 38.29
- P/B Ratio 3.43
- CapEx intensity
- DCF valuation (Overvalued)
- Earnings Surprise avg 0.2%
- Piotroski F-Score 2/9
データなし(8)
- EPS data insufficient
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- Return on Tangible Assets
- Low reliance on intangibles
- Price below Graham Number
- Share Dilution (missing shares data)
Piotroski F-スコア
重大な財務上の懸念
利益の質
高品質:利益はキャッシュに裏付けられている
株式希薄化
株式を買い戻している。株主に友好的
ガバナンス
経営陣
| 氏名 | 役職 | 年齢 |
|---|---|---|
| Dr. Roland Busch Dipl.Phys. | President, CEO & Chairman of Management Board | 61 |
| Ms. Veronika Bienert | CFO & Member of Management Board | 52 |
| Mr. Cedrik Neike | CEO of Digital Industries & Member of Managing Board | 52 |
| Ms. Judith Wiese | Chief People & Sustainability Officer and Member of Managing Board | 54 |
| Dr. Peter Koerte Ph.D. | CTO, CEO of Siemens Smart Infrastructure, Chief Strategy Officer & Member of Management Board | 50 |
| Dr. Ralf P. Thomas | Special Advisor | 64 |
| Dr. Andreas Christian Hoffmann | General Counsel, Head of the Legal & Compliance Department | 61 |
| Mr. Hanno Kunkel | Chief Compliance Officer and Head of the Global Compliance Organization & Human Rights Officer | 50 |
| Ms. Christiane Ribeiro Guimaraes Hofer | Global Head of Communications | 47 |
| Dr. Jochen Schmitz Ph.D. | Chief Financial Officer of Siemens Healthineers | 59 |
監査リスク
1
取締役会リスク
5
報酬リスク
1
株主権利リスク
1
パート2 · 株価と買い時
この部分は企業に価値があるかを判断するものではありません。ファンダメンタルズに納得したうえで、いつ買うかを選ぶためのものです。内容:テクニカル分析、ポテンシャル、過去のドローダウン、ガンマエクスポージャー。
Latest News
Recent headlines for SMAWF, sourced from Markets Gazette.